Mr Abdulfattah Al-Kadash
Casual Academic
School of Pharmacy and Pharmaceutical Sciences
Book Chapter
Esawi, Ezaldeen, Nsairat, Hamdi, Mahmoud, Ismail Sami, Lafi, Zainab, Al-Kadash, Abdulfattah, Al-Ragheb, Bayan Abu, Ismail, Said I. and Alhaer, Walhan (2023). Clinical use and future perspective of aptamers. Aptamers engineered nanocarriers for cancer therapy. (pp. 481-520) edited by Prashant Kesharwani. Cambridge, MA, United States: Elsevier. doi: 10.1016/b978-0-323-85881-6.00013-0
Journal Articles
Al-Kadash, Abdulfattah, Alshaer, Walhan, Mahmoud, Ismail Sami, Wehaibi, Suha and Zihlif, Malek (2024). Enhancing chemosensitivity of PANC1 pancreatic cancer cells to gemcitabine using ANGTPL4, Notch1 and NF-κβ1 siRNAs. Future Science OA, 10 (1) FSO918. doi: 10.2144/fsoa-2023-0145
Kanai, Masahiro, Andrews, Shea J., Cordioli, Mattia, Stevens, Christine, Neale, Benjamin M., Daly, Mark, Ganna, Andrea, Pathak, Gita A., Iwasaki, Akiko, Karjalainen, Juha, Mehtonen, Juha, Pirinen, Matti, Chwialkowska, Karolina, Trankiem, Amy, Balaconis, Mary K., Veerapen, Kumar, Wolford, Brooke N., Ahmad, Hajar Fauzan, Andrews, Shea, von Hohenstaufen Puoti, Kathrin Aprile, Boer, Cindy, Boua, Palwende R., Butler-Laporte, Guillaume, Cadilla, Carmen L., Colombo, Francesca, Douillard, Venceslas, Dueker, Nicole, Dutta, Atanu Kumar, El-Sherbiny, Yasser M. ... Menéndez-Valladares, Paloma (2023). A second update on mapping the human genetic architecture of COVID-19. Nature, 621 (7977), E7-E26. doi: 10.1038/s41586-023-06355-3
Alshaer, Walhan, Nsairat, Hamdi, Lafi, Zainab, Hourani, Omar M., Al-Kadash, Abdulfattah, Esawi, Ezaldeen and Alkilany, Alaaldin M. (2022). Quality by design approach in liposomal formulations: robust product development. Molecules, 28 (1) 10, 1-19. doi: 10.3390/molecules28010010
Aljabali, Alaa A. A., Obeid, Mohammad A., Bakshi, Hamid A., Alshaer, Walhan, Ennab, Raed M., Al-Trad, Bahaa, Al Khateeb, Wesam, Al-Batayneh, Khalid M., Al-Kadash, Abdulfattah, Alsotari, Shrouq, Nsairat, Hamdi and Tambuwala, Murtaza M. (2022). Synthesis, characterization, and assessment of anti-cancer potential of ZnO nanoparticles in an in vitro model of breast cancer. Molecules, 27 (6) 1827, 1-13. doi: 10.3390/molecules27061827
Alshaer, Walhan, Zureigat, Hadil, Al Karaki, Arwa, Al-Kadash, Abdulfattah, Gharaibeh, Lobna, Hatmal, Ma'mon M., Aljabali, Alaa A.A. and Awidi, Abdalla (2022). Corrigendum to “siRNA: Mechanism of action, challenges, and therapeutic approaches” [Eur. J. Pharmacol. 905 (2021) 174178] (European Journal of Pharmacology (2021) 905, (S0014299921003319), (10.1016/j.ejphar.2021.174178)). European Journal of Pharmacology, 916 174741, 174741. doi: 10.1016/j.ejphar.2022.174741
Al Tbakhi, Bayan, Nsairat, Hamdi, Alshaer, Walhan, Al-Kadash, Abdulfattah, Helal, Wissam, Alrawashdeh, Lubna, Day, Anthony, Assaf, Khaleel I., Hassouneh, Rola, Odeh, Fadwa and Al Bawab, Abeer (2022). Cinnamaldehyde–cucurbituril complex: investigation of loading efficiency and its role in enhancing cinnamaldehyde in vitro anti-tumor activity. RSC Advances, 12 (12), 7540-7549. doi: 10.1039/d2ra00044j
Gharaibeh, Lobna, Alshaer, Walhan, Wehaibi, Suha, Al Buqain, Rula, Alqudah, Dana A., Al-Kadash, Abdulfattah, Al-Azzawi, Hafsa, Awidi, Abdalla and Bustanji, Yasser (2021). Fabrication of aptamer-guided siRNA loaded lipopolyplexes for gene silencing of notch 1 in MDA-mb-231 triple negative breast cancer cell line. Journal of Drug Delivery Science and Technology, 65 102733, 1-10. doi: 10.1016/j.jddst.2021.102733
Alshaer, Walhan, Zureigat, Hadil, Al Karaki, Arwa, Al-Kadash, Abdulfattah, Gharaibeh, Lobna, Hatmal, Ma'mon M., Aljabali, Alaa A.A. and Awidi, Abdalla (2021). siRNA: mechanism of action, challenges, and therapeutic approaches. European Journal of Pharmacology, 905 174178, 1-21. doi: 10.1016/j.ejphar.2021.174178